251 related articles for article (PubMed ID: 26795621)
1. Effects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts.
Zafar S; Coates DE; Cullinan MP; Drummond BK; Milne T; Seymour GJ
Clin Oral Investig; 2016 Nov; 20(8):2023-2035. PubMed ID: 26795621
[TBL] [Abstract][Full Text] [Related]
2. Zoledronic acid and geranylgeraniol regulate cellular behaviour and angiogenic gene expression in human gingival fibroblasts.
Zafar S; Coates DE; Cullinan MP; Drummond BK; Milne T; Seymour GJ
J Oral Pathol Med; 2014 Oct; 43(9):711-21. PubMed ID: 24762323
[TBL] [Abstract][Full Text] [Related]
3. Effects of zoledronic acid and geranylgeraniol on angiogenic gene expression in primary human osteoclasts.
Zafar S; P Cullinan M; K Drummond B; J Seymour G; E Coates D
J Oral Sci; 2020; 62(1):79-83. PubMed ID: 31996529
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Real-Time Gene Profiling of Human Alveolar Osteoblasts.
Coates DE; Zafar S; Milne TJ
Methods Mol Biol; 2017; 1537():447-459. PubMed ID: 27924611
[TBL] [Abstract][Full Text] [Related]
5. PRGF exerts a cytoprotective role in zoledronic acid-treated oral cells.
Anitua E; Zalduendo M; Troya M; Orive G
Clin Oral Investig; 2016 Apr; 20(3):513-21. PubMed ID: 26201455
[TBL] [Abstract][Full Text] [Related]
6. Cytoprotective effects of melatonin on zoledronic acid-treated human osteoblasts.
Camacho-Alonso F; Urrutia-Rodríguez I; Oñate-Cabrerizo D; Oñate-Sánchez RE; Rodríguez-Lozano FJ
J Craniomaxillofac Surg; 2017 Aug; 45(8):1251-1257. PubMed ID: 28552199
[TBL] [Abstract][Full Text] [Related]
7. The bisphosphonate zoledronic acid regulates key angiogenesis-related genes in primary human gingival fibroblasts.
Ohlrich EJ; Coates DE; Cullinan MP; Milne TJ; Zafar S; Zhao Y; Duncan WD; Seymour GJ
Arch Oral Biol; 2016 Mar; 63():7-14. PubMed ID: 26658366
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro.
Huang X; Huang S; Guo F; Xu F; Cheng P; Ye Y; Dong Y; Xiang W; Chen A
Mol Med Rep; 2016 Jan; 13(1):613-22. PubMed ID: 26648136
[TBL] [Abstract][Full Text] [Related]
9. Zoledronic acid at subtoxic dose extends osteoblastic stage span of primary human osteoblasts.
Zara S; De Colli M; di Giacomo V; Zizzari VL; Di Nisio C; Di Tore U; Salini V; Gallorini M; Tetè S; Cataldi A
Clin Oral Investig; 2015 Apr; 19(3):601-11. PubMed ID: 25055744
[TBL] [Abstract][Full Text] [Related]
10. The influence of geranylgeraniol on human oral keratinocytes after bisphosphonate treatment: An in vitro study.
Pabst AM; Krüger M; Ziebart T; Jacobs C; Sagheb K; Walter C
J Craniomaxillofac Surg; 2015 Jun; 43(5):688-95. PubMed ID: 25913629
[TBL] [Abstract][Full Text] [Related]
11. Cytoprotective effects of melatonin on zoledronic acid-treated human mesenchymal stem cells in vitro.
Rodríguez-Lozano FJ; García-Bernal D; Ros-Roca Mde L; Algueró Mdel C; Oñate-Sánchez RE; Camacho-Alonso F; Moraleda JM
J Craniomaxillofac Surg; 2015 Jul; 43(6):855-62. PubMed ID: 26026888
[TBL] [Abstract][Full Text] [Related]
12. Mevalonates restore zoledronic acid-induced osteoclastogenesis inhibition.
Nagaoka Y; Kajiya H; Ozeki S; Ikebe T; Okabe K
J Dent Res; 2015 Apr; 94(4):594-601. PubMed ID: 25535203
[TBL] [Abstract][Full Text] [Related]
13. Geranylgeraniol - a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw.
Ziebart T; Koch F; Klein MO; Guth J; Adler J; Pabst A; Al-Nawas B; Walter C
Oral Oncol; 2011 Mar; 47(3):195-201. PubMed ID: 21247791
[TBL] [Abstract][Full Text] [Related]
14. Effects of pamidronate on human alveolar osteoblasts in vitro.
Marolt D; Cozin M; Vunjak-Novakovic G; Cremers S; Landesberg R
J Oral Maxillofac Surg; 2012 May; 70(5):1081-92. PubMed ID: 21856057
[TBL] [Abstract][Full Text] [Related]
15. Geranylgeraniol Restores Zoledronic Acid-Induced Efferocytosis Inhibition in Bisphosphonate-Related Osteonecrosis of the Jaw.
Chen X; Zhu W; Xu R; Shen X; Fu Y; Cheng J; Liu L; Jiang H
Front Cell Dev Biol; 2021; 9():770899. PubMed ID: 34805177
[TBL] [Abstract][Full Text] [Related]
16. In vivo effects of geranylgeraniol on the development of bisphosphonate-related osteonecrosis of the jaws.
Koneski F; Popovic-Monevska D; Gjorgoski I; Krajoska J; Popovska M; Muratovska I; Velickovski B; Petrushevska G; Popovski V
J Craniomaxillofac Surg; 2018 Feb; 46(2):230-236. PubMed ID: 29233701
[TBL] [Abstract][Full Text] [Related]
17. Bifunctional effect of Zoledronic Acid (ZA) on human mesenchymal stem cells (hMSCs) based on the concentration level.
Fliefel R; El Ashwah A; Entekhabi S; Kumbrink J; Ehrenfeld M; Otto S
J Stomatol Oral Maxillofac Surg; 2020 Dec; 121(6):634-641. PubMed ID: 32171967
[TBL] [Abstract][Full Text] [Related]
18. Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition.
Patntirapong S; Singhatanadgit W; Chanruangvanit C; Lavanrattanakul K; Satravaha Y
J Oral Pathol Med; 2012 Oct; 41(9):713-20. PubMed ID: 22563819
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates inhibit cell functions of HUVECs, fibroblasts and osteogenic cells via inhibition of protein geranylgeranylation.
Hagelauer N; Ziebart T; Pabst AM; Walter C
Clin Oral Investig; 2015 Jun; 19(5):1079-91. PubMed ID: 25261400
[TBL] [Abstract][Full Text] [Related]
20. Zoledronic acid induces apoptosis via stimulating the expressions of ERN1, TLR2, and IRF5 genes in glioma cells.
Biray Avci C; Kurt CC; Tepedelen BE; Ozalp O; Goker B; Mutlu Z; Dodurga Y; Elmas L; Gunduz C
Tumour Biol; 2016 May; 37(5):6673-9. PubMed ID: 26646564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
